Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Study to Identify the Opioid-sparing Effects, and Pain-reduction Potential of Low Dose Ketamine on Patients Undergoing TEVAR Procedures Receiving NCI

To see complete record on, please visit this link

Id: NCT04600089

Organisation Name: University of Kentucky

Overal Status: Recruiting

Start Date: December 8, 2020

Last Update: May 20, 2022

Lead Sponsor: Anna Rockich

Brief Summary: The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).

  • Descending Aortic Dissection
  • Postoperative Pain
  • Thoracoabdominal Aortic Aneurysm

Total execution time in seconds: 0.49104714393616